Conclusions

• Economic evaluation can aid decision-making

• In HCV economic assessments are needed to evaluate costs and effects over the lifetime

• Treatments for HCV appear relatively cost-effective

• However uncertainty surrounds results

• Issue of screening for HCV needs addressing

• Outstanding issues:

  • transferability of results to different countries
  • affordability
  • equity

Previous slide

Back to first slide

View graphic version